Pristinamycin in the treatment of MSSA bone and joint infection-authors' response

J Antimicrob Chemother. 2016 Nov;71(11):3318. doi: 10.1093/jac/dkw341. Epub 2016 Sep 1.

F Valour^{1

2

3}, F Laurent^{2

3

4}, T Ferry^{5

2

3}; Lyon Bone and Joint Infection Study Group

Lyon Bone and Joint Infection Study Group:
Florence Ader, François Biron, André Boibieux, Evelyne Braun, Christian Chidiac, Fatiha Daoud, Tristan Ferry, Yves Gillet, Laure Hees, Johanna Lippmann, Patrick Miailhes, Thomas Perpoint, Sandrine Roux, Julien Saison, Marie-Paule Vallat, Florent Valour, Cédric Barrey, Jean-Baptiste Bérard, Fabien Boucher, Pierre Breton, Olivier Cantin, Frédéric Dalat, Romain Desmarchelier, Michel-Henry Fessy, Timothée Jacquesson, Emmanuel Jouanneau, Sébastien Lustig, Ali Mojallal, Philippe Neyret, Adrien Peltier, Olivier Reynaud, Hristo Shipkov, Francesco Signorelli, Thibault Vermersch, Anthony Viste, Céline Dupieux, Frederic Laurent, Jean-Philippe Rasigade, François Vandenesch, Francesco Giammarile, Marc Janier, Isabelle Morelec, Marie-Claude Gagnieu, Sylvain Goutelle, Michel Tod

¹ Department of Infectious Diseases, Hospices Civils de Lyon, 103 Grande-Rue de la Croix-Rousse, 69004 Lyon, France florent.valour@chu-lyon.fr.
² French Regional Reference Centre for Bone and Joint Infection, Hospices Civils de Lyon, Lyon, France.
³ International Centre for Research in Infectiology, INSERM U1111, Claude Bernard Lyon 1 University, Lyon, France.
⁴ Laboratory of Bacteriology, French National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France.
⁵ Department of Infectious Diseases, Hospices Civils de Lyon, 103 Grande-Rue de la Croix-Rousse, 69004 Lyon, France.

No abstract available

Publication types